BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3557262)

  • 1. [Secondary failure of oral diabetes therapy].
    Bergis K; Heilmann B
    Fortschr Med; 1987 Feb; 105(4):64-8. PubMed ID: 3557262
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclohexamide. A new oral hypoglycemic agent].
    Villaseñor A; Parra A; López Amor E; Rull JA; Lozano-Castañeda O
    Rev Invest Clin; 1967; 19(2):149-57. PubMed ID: 5317602
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral hypoglycemic agents as an alternative therapy for gestational diabetes.
    Hod M; Shafrir E
    Isr J Med Sci; 1995 Oct; 31(10):640-3. PubMed ID: 7591693
    [No Abstract]   [Full Text] [Related]  

  • 4. [Failure of oral hypoglycemic agents: clinical experiences in 20 years' follow-up].
    Aylwin CG; López G; García de los Riós M; Vial T; Pinto JL; Ojeda A; Orellana JL
    Rev Med Chil; 1988 Aug; 116(8):729-35. PubMed ID: 3255124
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of sulfonylureas in type 2 diabetes.
    Yildiz BO; Gürlek A
    Horm Metab Res; 1999 Apr; 31(4):293-4. PubMed ID: 10333089
    [No Abstract]   [Full Text] [Related]  

  • 6. [40 years of using sulfonylurea derivatives for treatment of diabetes].
    Sieradzki J
    Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
    Tseng CH; Huang TS
    Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral agent therapy in the treatment of type 2 diabetes.
    Feinglos MN; Bethel MA
    Diabetes Care; 1999 Apr; 22 Suppl 3():C61-4. PubMed ID: 10189564
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B
    Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I
    N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral therapy of type II diabetes].
    Haupt E; Schöffling K
    Med Klin (Munich); 1989 Apr; 84(4):203-7. PubMed ID: 2657363
    [No Abstract]   [Full Text] [Related]  

  • 12. The new oral antidiabetic drugs.
    Moss JM; Delawter DE
    Am Fam Physician; 1984 Nov; 30(5):119-21. PubMed ID: 6437197
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diamicron in the treatment of diabetes mellitus type 2].
    Balabolkin MI; Morozova TP; Chachiashvili MV
    Sov Med; 1987; (7):21-2. PubMed ID: 3317910
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experience with Glurenorm in type 2 diabetics with renal insufficiency].
    Rybka J; Gregorová A; Zmydlená A
    Vnitr Lek; 1988 Aug; 34(8):786-92. PubMed ID: 3176368
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypoglycemic symptoms in patients with type 2 diabetes in Asia-Pacific-Real-life effectiveness and care patterns of diabetes management: the RECAP-DM study.
    Chan SP; Ji LN; Nitiyanant W; Baik SH; Sheu WH
    Diabetes Res Clin Pract; 2010 Aug; 89(2):e30-2. PubMed ID: 20541826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral antidiabetic agents: what are the choices?].
    Crausaz FM
    Rev Med Suisse Romande; 1991 Aug; 111(8):701-5. PubMed ID: 1925244
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

  • 19. The diagnostic value of determining the hydroxy metabolite of glimepiride (M1) in blood serum in cases of severe hypoglycaemia associated with glimepiride therapy.
    Holstein A; Plaschke A; Ptak M; Egberts EH; Tenberken O; Maurer HH
    Diabetes Obes Metab; 2004 Sep; 6(5):391-3. PubMed ID: 15287933
    [No Abstract]   [Full Text] [Related]  

  • 20. Use oral hypoglycemics with caution...but keep caution in context.
    Davidson MB
    Geriatrics; 1988 Aug; 43(8):83-4. PubMed ID: 3042515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.